Last reviewed · How we verify
Intra-arterial injection of melphalan — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intra-arterial injection of melphalan (Intra-arterial injection of melphalan) — Hadassah Medical Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intra-arterial injection of melphalan TARGET | Intra-arterial injection of melphalan | Hadassah Medical Organization | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intra-arterial injection of melphalan CI watch — RSS
- Intra-arterial injection of melphalan CI watch — Atom
- Intra-arterial injection of melphalan CI watch — JSON
- Intra-arterial injection of melphalan alone — RSS
Cite this brief
Drug Landscape (2026). Intra-arterial injection of melphalan — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-arterial-injection-of-melphalan. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab